Pharmigene Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	56.49	92.34	68.53	76.86	104.29
Short-Term Investments	30.97	31.96	38.81	118.73	134.8
Trading Asset Securities	-	34.34	53.43	-	-
Cash & Short-Term Investments	87.46	158.64	160.78	195.59	239.09
Cash Growth	-44.87%	-1.33%	-17.80%	-18.19%	-19.63%
Accounts Receivable	53.16	12.87	25.66	27.43	17.31
Other Receivables	0.47	0.68	0.49	1.15	0.03
Receivables	53.63	13.55	26.15	28.58	17.34
Inventory	44.23	53.68	27.44	28.57	18.71
Prepaid Expenses	33.68	21.3	17.92	5.39	10.65
Other Current Assets	0.02	3.07	21.7	0.4	0.3
Total Current Assets	219	250.25	253.99	258.54	286.09
Property, Plant & Equipment	539.99	593.89	559.95	28.35	36.73
Long-Term Investments	50.29	16.3	86.11	67.18	70.81
Other Intangible Assets	11.12	13.44	14.07	14.03	15.96
Other Long-Term Assets	167.97	129.28	132.85	16.17	9.54
Total Assets	988.37	1,003	1,047	384.27	419.12
Accounts Payable	21.83	14.42	7.95	7.19	2.88
Accrued Expenses	-	10.18	11.37	10.06	7.92
Short-Term Debt	67.08	-	-	-	-
Current Portion of Long-Term Debt	16.23	12.94	-	-	-
Current Portion of Leases	1.94	3.85	6.53	5.35	6.99
Current Unearned Revenue	10.42	3.72	2.01	9.07	2.74
Other Current Liabilities	20.92	7.39	8.85	6.64	4.31
Total Current Liabilities	138.42	52.51	36.72	38.3	24.84
Long-Term Debt	568.63	597.46	559.4	-	-
Long-Term Leases	1.18	2.23	5.16	4.09	7.75
Long-Term Deferred Tax Liabilities	-	-	-	-	0.01
Other Long-Term Liabilities	1.71	1.88	1.57	2.13	4.3
Total Liabilities	709.94	654.08	602.85	44.52	36.9
Common Stock	504.65	504.65	504.65	434.65	434.65
Additional Paid-In Capital	-	105	105	-	-
Retained Earnings	-219.33	-251.34	-172.73	-100.09	-57.37
Comprehensive Income & Other	-6.89	-9.25	7.18	5.19	4.95
Shareholders' Equity	278.43	349.06	444.1	339.75	382.22
Total Liabilities & Equity	988.37	1,003	1,047	384.27	419.12
Total Debt	655.05	616.49	571.1	9.43	14.74
Net Cash (Debt)	-567.6	-457.84	-410.32	186.16	224.35
Net Cash Growth	-	-	-	-17.02%	-18.67%
Net Cash Per Share	-11.27	-9.07	-9.02	4.28	5.16
Filing Date Shares Outstanding	50.22	50.47	50.47	43.47	43.47
Total Common Shares Outstanding	50.22	50.47	50.47	43.47	43.47
Working Capital	80.58	197.74	217.27	220.24	261.25
Book Value Per Share	5.54	6.92	8.80	7.82	8.79
Tangible Book Value	267.31	335.63	430.04	325.72	366.26
Tangible Book Value Per Share	5.32	6.65	8.52	7.49	8.43
Land	-	284.6	284.6	-	-
Buildings	-	281.35	250.31	8.67	-
Machinery	-	53.11	39.53	35.16	46.37
Construction In Progress	-	3.17	13.11	-	-
Leasehold Improvements	-	-	-	-	8.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.